A21 – A Showcase of Innovation in Pharmacovigilance

Pharmacovigilance is not just case processing and regulatory reporting. In fact, there is a lot of potential for innovation as we have seen over the past few years in the risk minimisation space. But what else is happening  in the Australian PV environment? This session will explore innovative and ground breaking projects that could provide inspiration for your workplace:

  • Community pharmacists’ knowledge, opinions, and attitudes towards reporting adverse drug reactions (ADRs) in Australia: A cross-sectional survey
  • Access to health in developing countries – improving the safe use of medicine
  • Partnership Celgene & IBM Watson: Transforming patient safety monitoring

Chairperson: Sahar Bassal, Senior Manager, Drug Safety, Celgene